Superficial warming and cooling of the leg affects walking speed and neuromuscular impairments in people with spastic paraparesis by Denton, A et al.
1 
 
SUPERFICIAL WARMING AND COOLING OF THE LEG AFFECTS WALKING SPEED 1 
AND NEUROMUSCULAR FUNCTIONS IN PEOPLE WITH SPASTIC PARAPARESIS 2 
 3 
A. Denton, MSc †; L. Bunn, PhD†; A. Hough, PhD †; G. Bugmann, PhD ¥; J. Marsden, 4 
PhD† 5 
†School of Health Professions, Faculty of Health and Human Sciences, Plymouth University 6 
PL6 8BH    ¥ School of Computing and Mathematics, Faculty of Science and Environment 7 
Community Plymouth University UK 8 
 9 
Corresponding Author 10 
Mrs Amanda Denton MSc, BSc Hons, School of Health Professions, Faculty of Health and 11 
Human Sciences,  12 
Peninsula Allied Health Centre, Plymouth University, Derriford Road, Plymouth,Devon, PL6 13 
8BH, England  14 
Tel (business) (+44) 01752 587 995   Tel (home) (+44) 07729175442  Fax (+44) 01752 15 
588873       Email: amanda.denton@plymouth.ac.uk 16 
 17 
Abstract 208 18 
Main Text 3383 19 
Tables 3 20 
Figures 2 +1 online  21 
References 40  22 
 23 
 24 
 25 
2 
 
ABSTRACT 210 26 
Objective: People with Hereditary and Spontaneous Spastic Paraparesis (pwSP) report 27 
their legs are stiffer and walking slower when their legs are cold. This study explored the 28 
effects of prolonged superficial cooling and warming of the lower leg on walking speed and 29 
local measures of neuromuscular function.  30 
  31 
Methods: A randomised pre and post intervention study with 22 pwSP and 19 matched 32 
healthy controls. On two separate occasions one lower leg was cooled or warmed. 33 
Measurements included walking speed and measures of lower limb impairment: ankle 34 
movement, passive muscle stiffness, spasticity, amplitude and rate of force generation and 35 
central and peripheral nerve conduction time/velocity. 36 
 37 
Results: In both groups cooling led to a decrease in walking speed that was more marked in 38 
people with spastic paraparesis. Cooling decreased the rate and amplitude of force 39 
generation and peripheral nerve conduction velocity and increased stretch reflex size. 40 
Warming increased the rate and amplitude of force generation, nerve conduction velocity 41 
and decreased the size of the stretch reflex.   42 
 43 
Conclusion: Superficial cooling significantly reduces walking speed. Temperature changes 44 
are associated with changes in neuromuscular impairments in spastic paraparesis and 45 
controls.  Rehabilitation interventions that help to prevent heat loss (insulation) or improve 46 
limb temperature via passive or active means particularly when the legs and/or environment 47 
are cool may have benefits for people with spastic paraparesis.   48 
Keywords: temperature, neural conduction, muscle spasticity, spastic paraparesis 49 
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 51 
List of Abbreviations: 52 
MEP – Motor Evoked Potentials  53 
MVC – Maximal Voluntary Contraction 54 
MVCdt – Rate of rise of torque  55 
pwSP – people with Spastic Paraparesis  56 
TMS – Transcranial Magnetic Stimulation 57 
BMI – Body Mass Index  58 
 59 
 60 
 61 
 62 
 63 
 64 
 65 
 66 
 67 
 68 
INTRODUCTION 69 
Hereditary and Spontaneous Spastic Paraparesis is a progressive condition resulting in 70 
impaired balance and walking1. In the type I or uncomplicated presentation people present 71 
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with lower limb paresis and spasticity due to a dying back axonal degeneration of central 72 
descending and ascending tracts including the corticospinal tract, spinocerebellar tracts and 73 
the dorsal columns. In the type II or complicated presentation  additional signs include 74 
peripheral neuropathy, cerebellar ataxia or dementia1. Focus groups held with people with 75 
Hereditary and Spontaneous Spastic Paraparesis (pwSP) in the UK (n=36 participants) 76 
highlighted the perception that their walking is often slower when their legs are cold such as 77 
in cold weather, this is associated with an increase in perceived lower limb stiffness. 78 
Warming their lower legs by increasing layers of clothes or being in warmer environments is 79 
perceived to help them walk faster and relieve increased leg stiffness. 80 
In people with a stroke or an acquired brain injury a decrease in spasticity, as measured 81 
clinically and electrophysiologically10–13, has been reported with periods of superficial cooling. 82 
Despite this reduction in spasticity, improvements in voluntary movements and function have 83 
not been clearly demonstrated10. This may reflect the associated impact of temperature 84 
changes on nerve conduction velocity, passive stiffness14 and muscle strength.  85 
The subjective report of an improvement of function with warming in pwSP contrasts with 86 
people with Multiple Sclerosis who can also present with an upper motor neuron syndrome. 87 
People with Multiple Sclerosis often report a worsening of symptoms with warming and an 88 
improvement with whole body or localised cooling. This is mainly felt to be mediated by 89 
inducing central nerve conduction block with warming (Uthoffs Phenomenon) secondary to 90 
demyelination15,    . For this reason central conduction time was assessed in pwSP. 91 
 92 
 This study therefore investigated whether (a) pwSP experience changes in walking speed 93 
and measures of neuromuscular impairments (movement, stiffness, strength and nerve 94 
conduction velocity) with prolonged superficial cooling and warming and (b) whether these 95 
changes are comparable to that seen in healthy participants. Ultimately, this study aims to 96 
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determine whether rehabilitation strategies should consider the functional impact of 97 
temperature changes in pwSP. 98 
 99 
MATERIALS AND METHODS 100 
PARTICIPANTS 101 
Twenty two pwSP and 19 healthy controls, matched for age, gender and body mass index 102 
(BMI), participated in the study (Table 1).  PwSP were recruited via advertisement in the UK 103 
SP support group newsletter and controls via local advert. PwSP were included if they had a 104 
diagnosis of Spastic Paraparesis with/without a family history. Other differential diagnoses 105 
were excluded through appropriate imaging, clinical and laboratory tests. Participants had to 106 
be able to walk at least 20m with/without a walking aid and have bilateral spasticity in the 107 
ankle plantarflexors (at least grade 1 Ashworth score18). PwSP were excluded if they had 108 
additional orthopaedic/neurological impairments. Exclusion factors for both groups included 109 
contraindications to Transcranial Magnetic Stimulation (TMS), poor skin integrity, Raynaud’s 110 
disease or a fixed ankle inversion contracture. Ethical approval was provided by South West 111 
Cornwall and Plymouth ethics committee (HS13/14-105).  Informed consent was provided 112 
by all participants.  113 
 114 
Participants’ baseline characteristics (height, weight, age, sex, family history, genetic 115 
diagnosis, length of symptoms and presence of anti-spasticity medication) were recorded.  116 
The abbreviated mental test score was used to screen for dementia and a self-report Barthel 117 
Index recorded functional ability. Skin fold thickness overlying the ankle plantarflexors was 118 
measured using a Harpenden calliper at the level of the mid-shank in a seated position and 119 
Body mass index (BMI) calculated from people’s height and mass. The Ashworth scale was 120 
used to evaluate spasticity in the lower leg. PwSP were classified as pure or complicated 121 
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according to genetic diagnosis and the presence or absence of additional signs and 122 
symptoms, including  peripheral neuropathy2,23.  123 
 124 
INTERVENTION 125 
For pwSP the self-reported most affected side was studied, for healthy controls a similar 126 
proportion of dominant and non-dominant legs were assessed. Participants were assessed 127 
in a semi-reclined standardised position (Figure 1).  One lower leg was cooled or warmed for 128 
30 minutes using a wrap attached to a temperature controlled water bath with water 129 
circulating at either 7 oC or 37 oC, (Figure 1).The order of cooling or warming was 130 
randomised using a computer generated code and each condition was separated by a 131 
minimum 24hr period.  132 
 133 
MEASURES 134 
Core temperature was measured in the inner ear (Tympanic membrane temperature (Omron 135 
MC 510-E2, Netherlands). Room and shank skin temperature were measured using 136 
thermocouples (type-t thermocouples (BAT-10 Physitemp, USA).  137 
 138 
The primary outcome measure was maximal walking speed measured over a 10m walkway. 139 
Two walks were recorded with a 1 min seated rest period and the mean walking speed 140 
calculated.  141 
 142 
Secondary outcome measures evaluated neuromuscular impairments in the lower leg. 143 
Localised movement at the ankle was measured by foot tapping time. The time taken to tap 144 
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each foot 10 times was recorded with the subject in a standardised seated position.  The 145 
mean foot tap time was calculated for each side. 146 
  147 
Slow and fast stretches were used to quantify passive stiffness and stretch reflex size. A 15-148 
degree amplitude, slow (peak velocity 5 o/s) and fast (peak velocity 170 o/s) ramp stretch 149 
was applied at the ankle while the participant was relaxed. The ankle axis was aligned to the 150 
axis of a customised servomotor (Baldor BSM, UK (Figure 1)). Each stretch was repeated 6 151 
times with a 3-5 second random inter-stretch interval. Torque, position (TLSF transducer, 152 
Industrial measurements UK) and surface electromyography from the tibialis anterior, medial 153 
gastrocnemius and soleus muscles (2.5 cm inter-electrode distance, Digitimer D360, UK) 154 
were recorded. During the 6 slow stretches, trials were omitted if the EMG was greater than 155 
the mean + 2 SD of the pre-stretch relaxed level (baseline level). Torque, position and EMG 156 
were digitized (2KHz Power 1401, CED Electronics, UK). EMG signals were filtered (30Hz 157 
low pass 2nd Order Butterworth filtered) and rectified (MATLAB (Mathworks, USA)). Torque 158 
and position were measured over a 300ms period prior to stretch onset and immediately 159 
following stretch offset. Slow stretches evaluated passive stiffness24. 160 
 161 
Stiffness was normalised to body weight and defined as:  ∆Torque / ∆ position  162 
 163 
 Stretch reflex activity was characterised by the mean rectified gastrocnemius EMG above 164 
baseline level following the fast stretch and used as a measure of spasticity. 165 
 166 
Maximal isometric muscle strength (MVC) of ankle plantar- and dorsiflexors was measured 167 
using the motor with the ankle in 5o plantarflexion.  The participant was asked to push down 168 
8 
 
or pull up as hard and fast as they could and verbal encouragement was provided. The rate 169 
of torque development (MVCdt) was defined as the rate torque developed between 25-50% 170 
of the maximal torque as calculated using a least squares algorithm. 171 
 172 
Peripheral nerve conduction was measured in the tibial nerve. The latency of abductor 173 
hallucis M waves following proximal stimulation at the level of the popliteal fossa and distal 174 
stimulation at the level of the medial malleolus were recorded. The stimulation points were 175 
marked for recording following cooling/warming and the distance between distal and 176 
proximal points measured. Conduction velocity (m/s) was defined as: 177 
 178 
Inter-stimulus distance/ (proximal-distal M wave latency)25 179 
 180 
For central conduction times, motor evoked potentials (MEPs) in the abductor hallucis in 181 
response to single pulse TMS were measured26 (double cone coil 110mm Magstim 200 182 
stimulator, Magstim company, UK). Resting threshold was determined as the stimulus that 183 
produced an MEP >50 μV on at least 3 out of 5 occasions26.  MEP latency was measured 184 
following 3 stimuli at 1.5 x resting motor threshold up to 100% machine output (2.0 T). In 2 185 
pwSP MEPs at a resting threshold could not be determined therefore MEPs were recorded 186 
at 100% machine output as they contracted abductor hallucis (~10% maximal voluntary 187 
contraction). Lumbosacral roots were stimulated using a figure of eight coil (70 mm) that was 188 
placed lateral to the L5 spinous process, oriented 45o to the vertical with the coil current 189 
running in a medio-lateral direction. Stimulator intensity >80% was used to record abductor 190 
hallucis MEPs 27.   191 
 192 
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The central conduction time was defined as: motor cortex MEP latency- spinal root MEP 193 
latency. 194 
 195 
All measures were repeated before and immediately after 30 minutes of superficial cooling 196 
or warming.  197 
 198 
ANALYSIS 199 
Tests of normality (Shapiro-Wilks) established that data from all measures was normally 200 
distributed. Baseline characteristics were compared using unpaired t-tests. Changes in 201 
walking speed and neuromuscular measures of impairment were assessed using a between 202 
groups repeated measures analysis of variance with factors being GROUP (pwSP Vs 203 
Controls), TIME (pre vs post intervention) and TEMPERATURE (cool vs warm). An 204 
additional factor of SIDE (targeted vs non targeted) was included when assessing changes 205 
in foot tap time. Results were taken as significant if p≤0.05.  206 
 207 
RESULTS 208 
Participant demographics are summarised in Table 1. There was no difference in age or BMI 209 
between groups (P>0.05, Table1).  Calf skin thickness was less in pwSP (p<0.005, Table 1). 210 
Clinical characteristics of pwSP are summarised in Table 2. When people with complicated 211 
and pure presentations of spastic paraparesis were compared at baseline people with 212 
complicated presentations had slower walking (t test p<0.001) and foot tap times ( t test 213 
p<0.05) but there was no difference for all other measures. Therefore both presentations 214 
were analysed as one group (pwSP). 215 
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There were no differences between pwSP or control groups in core or room temperature 216 
(Effect of Group p>0.05). This did not change over time (Effect of Time >0.05) and there 217 
were no interaction effects. There were no Group or Time effects for skin temperature (Effect 218 
of Group p>0.05; effect of Time p>0.05). There was a Time x Temperature interaction 219 
(p<0.001, Table 3). Over 30 minutes local skin temperature decreased with cooling by 12.1 ± 220 
2.35 oC and increased with warming by 9.37 ± 2.18 oC. 221 
 222 
Walking speed was significantly slower in pwSP (Effect of Group p<0.001).  Overall walking 223 
speed slowed over time (Effect of Time p<0.05) and was slower in the cooling condition 224 
(Effect of Temperature p<0.05).  This reflected the fact that walking speed decreased 225 
significantly with localised cooling in both groups whilst there was no change in walking 226 
speed with localised warming (Temperature x Time Interaction (p<0.005; Figure 2A)).  227 
 228 
Foot tap time was significantly longer in pwSP (Effect of Group P<0.0001). In both groups 229 
foot tap time significantly increased with cooling and decreased with warming (Temperature 230 
x Time Interaction p<0.001); this occurred in the targeted leg only (Temperature x Side x 231 
Time Interaction effect (p<0.001; table 3, Figure 2B). The decrease in foot tap time when the 232 
leg was warmed was significantly greater in pwSP compared to controls (Temperature x 233 
Time x Side x Group Interaction p<0.05), whilst the increase in foot tap times seen after 234 
cooling was of similar magnitude in both groups.   235 
Passive stiffness was higher in pwSP compared to controls (Effect of Group p<0.0001). 236 
Passive stiffness decreased with cooling and warming (Effect of Time p<0.001). The 237 
decrease in passive stiffness was greater with in pwSP (Time x Group Interaction p<0.05, 238 
Table 3).  239 
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Stretch reflex size (spasticity) was higher in pwSP (Effect of Group p<0.01). The size of the 240 
stretch reflex  significantly  decreased with warming and increased with cooling 241 
(Temperature x Time interaction p<0.05, table 3). 242 
 243 
Dorsiflexor MVC was significantly reduced in pwSP (Effect of Group p<0.0001, table 3). 244 
Dorsiflexor MVC decreased with cooling and warming (Effect of Timep<0.0001).  The 245 
reduction in MVC with cooling was more marked than that observed with warming 246 
(Temperature x Time Interaction p<0.0001) and was greater in the control group 247 
(Temperature x Time x Group interaction p<0.0001, Table 3). Plantarflexor strength as 248 
measured by MVC was significantly reduced in pwSP (p<0.0001). PF MVC decreased over 249 
time (Effect of Time p<0.05); there were no other interaction effects.  250 
 251 
The rate of torque generation in dorsiflexor and plantarflexor muscles (MVCdt) was 252 
significantly reduced in pwSP (Effect of Group p<0.0001). In both groups MVCdt decreased 253 
with cooling and increased with warming (Temperature x Time Interaction Dorsiflexors 254 
p<0.001Plantarflexors P<0.001). The reduction in MVCdt with cooling was more marked in 255 
the control group (Effect of Temperature x Time x Group Dorsiflexors : p<0.001, 256 
Plantarflexors: P<0.05, Table 3). 257 
 258 
Data on peripheral tibial nerve conduction was obtained in 20 pwSP and 16 controls, with 259 
missing data relating to perceived discomfort with the procedure. There was no difference in 260 
conduction velocity between groups (p=0.06). Four pwSP (20%) had a tibial nerve 261 
conduction velocity over two standard deviations lower than the control mean at baseline 262 
and were classified as having a peripheral neuropathy23 (Table 2).  Tibial nerve conduction 263 
velocity decreased with cooling and increased with warming (Temperature x Time Interaction 264 
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(p<0.001), Figure 3, Table 3). Changes in conduction velocity with cooling and warming 265 
were not significantly different between the groups. 266 
 267 
Data on central conduction time was obtained in 14 pwSP (64%) and 13 Controls (68%), 268 
with dropouts being caused by perceived discomfort with the procedure. At baseline pwSP 269 
had a longer central conduction time (Effect of Group p<0.05). Central motor conduction 270 
time was not affected by temperature changes in either group (p>0.05, Table 3). 271 
 272 
There was no effect of skin thickness on the extent of temperature-related changes in 273 
physiological or functional variables.  274 
 275 
DISCUSSION 276 
In the current study 77% of pwSP (n=22) had a genetic diagnosis and/or family history, and 277 
both complicated (n=5) and uncomplicated (n=17) presentations were seen as defined by 278 
clinical presentation/genetic testing (Table 2). The proportion of pwSP with a genetic 279 
diagnosis is similar to that reported in epidemiological studies28–30 and reflects the multitude 280 
of genetic mutations that can cause this condition. PwSP had an increased corticospinal 281 
tract conduction time in keeping with the axonal degeneration reported using MRI, diffusion 282 
tensor imaging and post mortem32–34. At baseline increased spasticity (stretch reflex size), 283 
passive stiffness, reduced MVC in dorsiflexor and plantarflexor muscles and slower walking 284 
speeds were seen in pwSP compared to controls in line with previous reports24,3135.  285 
The level of spasticity reported could be considered to be low (median grade 1; range 1-3); 286 
this could reflect a bias towards recruiting people with more mild symptoms. However, an 287 
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assessment of their walking ability suggests that the cohort of ambulant pwSP studied was 288 
more severe with 78% using walking aids compared to 28% in population studies37. 289 
The impact of superficial cooling on walking speed supports subjective reports of pwSP that 290 
their walking gets slower when their legs are cold. At a more local level localised ankle 291 
movement measured by foot tap time increased in the targeted limb with cooling and 292 
decreased with warming. Deteriorations in toe tapping time with cooling have been reported 293 
previously in people with acquired brain injury11. Spastic Paraparesis produces bilateral 294 
spasticity and paresis; only 1 leg was targeted in this study to allow a detailed study of the 295 
changes in neuromuscular impairments in that leg and assess their subsequent effects on 296 
walking. More marked effects would be expected with targeting both legs although limited 297 
time post cooling / warming precluded an assessment of both legs36.  298 
 299 
Group differences in the effects of temperature changes may be related to the reduction in 300 
calf skin thickness in pwSP. Reductions in skin thickness have been reported in other 301 
neurological conditions38 and may lead to more marked changes in intramuscular 302 
temperature with cooling/warming39. However, there was no difference in the impact of 303 
temperature on tibial nerve conduction velocity between groups suggesting that temperature 304 
changes, at least at this deeper level, may be similar.  305 
 306 
A decrease in passive stiffness was observed in both groups with cooling and warming. The 307 
passive stiffness changes observed in both conditions may reflect the effects of the repeated 308 
slow and fast stretches used to test stiffness and spasticity and/or the fact that the ankle was 309 
held in 5o plantarflexion for the 30 minute intervention period that may have reduced the 310 
viscoelastic properties of the muscle. That these changes were more marked in pwSP 311 
suggests that stretching may be a useful adjunct to treatment. Cooling and warming have 312 
both been reported to have effects on muscle spindle activity with changes in muscle spindle 313 
14 
 
sensitivity occurring alongside changes in the firing rate of Ia afferents6,41. Ice has been used 314 
therapeutically to reduce spasticity42. In contrast in this study stretch reflex size increased 315 
with cooling. Noxious stimuli such as sudden superficial application of cold to the skin may 316 
increase spasticity45. However, this will only have an effect for a few seconds14. Warming 317 
resulted in a reduction in spasticity; this may in part underlie the reductions in spastcity seen 318 
with hydrotherapy in this patient group43.  319 
 320 
A reduced MVC was seen in dorsiflexors but not plantarflexors with cooling.  This may reflect 321 
the fact that the common peroneal nerve supplying the ankle dorsiflexors is more superficial 322 
than the tibial nerve supplying the ankle plantarflexors. The rate of torque generation in the 323 
dorsiflexor muscles (MVCdt) decreased significantly with cooling and increased with 324 
warming in both groups. This has not been reported previously in people with neurological 325 
conditions. The ability to rapidly generate force in the dorsiflexor muscles is key in the gait 326 
cycle for swing through and to reduce tripping. For pwSP the prevention of cooling of these 327 
muscles may therefore also be important for risk of falls measurement of falls could be 328 
incorporated into future studies.   329 
Superficial cooling or warming was applied to the lower leg and therefore both the flexor and 330 
extensor muscle compartments were targeted. In future it would be interesting to target 331 
either compartment. This could, for example, help differentiate between the functional impact 332 
of plantarfexor spasticity and dorsiflexor paresis in causing foot drop that is reported to lead 333 
to trips and falls in pwSP.  334 
 335 
This study induced localised temperature changes that are more marked than usually 336 
encountered in the environment. However, changes in environmental temperature would 337 
affect the whole body, possibly leading to more widespread (but less marked) changes than 338 
seen in the current study that may still affect functional ability39. Future work could assess 339 
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the effects of changes in ambient temperature. This study looked at the effects of superficial 340 
warming from an ambient room temperature of 22.96±1.94°C. It may be that the 341 
improvements in neuromuscular impairments  seen in this study with warming are more 342 
marked in cooler environments.  343 
The application of superficial heating or cooling has been suggested to have a depth of 344 
effect of 10-30mm depth47 although some studies have suggested changes at deeper levels 345 
with superficial application of heat48,49. This study used non-invasive skin temperature 346 
measurement was used which has been reported to correlate to deeper intramuscular 347 
temperatures3,50 and was a pragmatic decision in this study.   In this study regardless of the 348 
depth of effect changes in walking speed and neuromuscular impairments were observed 349 
which suggest an effect on neuromuscular structures. Future studies could include 350 
intramuscular temperature monitoring to evaluate the precise depth of temperature 351 
penetration3.  352 
This study highlights several implications for rehabilitation of pwSP. In pwSP, superficial 353 
cooling led to a deterioration in functional ability as measured by walking speed as well as 354 
changes in local neuromuscular impairments which would tend to support the observations 355 
of pwSP that their walking deteriorates when their limbs are cold. Avoidance of cooling by 356 
the use of insulating garments should be evaluated in pwSP. Superficial warming resulted in 357 
improvements in torque generation, a reduction in spasticity and passive stiffness, as well as 358 
a quicker nerve conduction speed. External passive heating or active warm up17, or 359 
hydrotherapy to increase limb temperature should be explored further in pwSP. As 360 
movement is impaired in pwSP it may be that maintaining and preventing heat loss or 361 
increasing limb temperature using passive means may be more efficient and effective in this 362 
patient group.  363 
 364 
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As discussed above limitations include the impact of difference in skin thickness and the lack 365 
of recordings of temperature in subcutaneous tissues. Further, although order effects were 366 
minimised by randomising the order of presentation the assessors were not blinded to the 367 
type of intervention. Future work could therefore assess the effects of more clinically feasible 368 
methods of cooling/warming and/or the impact of environmental changes. Blinded outcome 369 
measurement of not only neuromuscular impairment but also subjective and objective 370 
measures of functional ability should be included. 371 
 372 
CONCLUSIONS 373 
Superficial cooling of a limb affects both walking speed and localised measures of 374 
neuromuscular impairments (ankle movement,  dorsiflexor strength, passive stiffness, 375 
spasticity and nerve conduction speed) in pwSP and control participants. Warming does not 376 
have an effect on walking speed but it does result in improvements in neuromuscular 377 
functions: localised ankle movement, nerve conduction speed, passive stiffness, spasticity 378 
and ability to rapidly generate force in dorsiflexor muscles. Rehabilitation interventions that 379 
help to prevent heat loss or increase limb temperature via passive means may have 380 
functional benefits for pwSP.  381 
 382 
Acknowledgements: Acknowledgement of assistance to Julie Soane and Adam Carter for 383 
assistance in building the temperature controlled wrap, Guido Bugmann and Peter Gibbons 384 
for assistance in building the servomotor and the HSP support group UK for help recruiting in 385 
particular Ian Bennett and Simon Hubbard. Congresses: Acknowledgement of oral 386 
presentation of this research: European Society of Physical Rehabilitation Medicine, 387 
Marseille 2014, Physiotherapy UK 2014. Funding: Acknowledgement of financial support for 388 
this study kindly provided by the Physiotherapy Research Foundation: The Chartered 389 
Society of Physiotherapy, UK.  390 
17 
 
 391 
Conflicts of interest: None 392 
 393 
References 394 
1.  Salinas S, Proukakis C, Crosby A, Warner TT. Hereditary spastic paraplegia : clinical 395 
features and pathogenetic mechanisms. Lancet Neurol. 2008;7(12):1127–1138. 396 
doi:10.1016/S1474-4422(08)70258-8. 397 
2.  McDermott C. Hereditary spastic paraparesis: a review of new developments. J 398 
Neurol Neurosurg Psychiatry. 2000;69(2):150–160. doi:10.1136/jnnp.69.2.150. 399 
3.  Rutkove S. Effects of Temperature on Neuromuscular Electrophysiology. Muscle and 400 
Nerve. 2001;24:867–882. 401 
4.  Halar E, Delisa J, Brozovich F. Peroneal nerve conduction velocity: the importance of 402 
temperature correction. Arch Phys Med Rehabil. 1981;62(9):439–443. 403 
5.  Bell K, Lehmann J. Effect of cooling on H- and T-reflexes in normal subjects. Arch 404 
Phys Med Rehabil. 1987;68(8):490–493. 405 
6.  Mense S. Effects of temperature on the discharges of muscle spindles and tendon 406 
organs. Pflügers Arch. 1978;374(2):159–156. Available at: 407 
http://link.springer.com/article/10.1007/BF00581297. 408 
7.  Rigby BJ, Hirai N, Spikes JD, Eyring H. The Mechanical Properties of Rat Tail Tendon. 409 
J Gen Physiol. 1959;43(2):265–83. Available at: 410 
http://www.ncbi.nlm.nih.gov/pubmed/21821131. 411 
8.  Lakie M, Walsh E, Wright G. Control and postural thixotrophy of forearm muscles: 412 
changes caused by cold. J Neurol Neurosurg Psychiatry. 1986;49:69–76. 413 
9.  Proske U, Morgan DL. Do cross-bridges contribute to the tension during stretch of 414 
passive muscle? J Muscle Res Cell Motil. 1999;20(5-6):433–42. Available at: 415 
http://www.ncbi.nlm.nih.gov/pubmed/10555062. 416 
10.  Harlaar J, Kate J, Prevo A, Vogelaar T, Lankhorst G. The effect of cooling on muscle 417 
co-ordination in spasticity: assessment with the repetitive movement test. Disabil 418 
Rehabil. 2001;23(11):453–461. 419 
11.  Allison SC, Abraham LD. Sensitivity of qualitative and quantitative spasticity 420 
measures to clinical treatment with cryotherapy. Int J Rehabil Res. 2001;24(1):15–24. 421 
doi:10.1097/00004356-200103000-00003. 422 
12.  Matsumoto S, Shimodozono M, Etoh S, Tanaka N, Kawahira K. P35-16 Beneficial 423 
effects of footbaths in controlling spasticity after stroke: F-wave study. Clin 424 
Neurophysiol. 2010;121(Cc):S315. doi:10.1016/S1388-2457(10)61286-2. 425 
13.  Matsumoto S, Kawahira K, Etoh S, Ikeda S, Tanaka N. Short-term effects of 426 
thermotherapy for spasticity on tibial nerve F-waves in post-stroke patients. Int J 427 
Biometeorol. 2006;50(4):243–250. 428 
14.  Price R, Lehmann J. Influence of muscle cooling on the viscoelastic response of the 429 
human ankle to sinusoidal displacements. Arch Phys Med Rehabil. 1990;71:745–748. 430 
15.  Humm AM, Beer S, Kool J, Magistris MR, Kesselring J, Rösler KM. Quantification of 431 
Uhthoff’s phenomenon in multiple sclerosis: A magnetic stimulation study. Clin 432 
18 
 
Neurophysiol. 2004;115(11):2493–2501. doi:10.1016/j.clinph.2004.06.010. 433 
16.  Guthrie TC, Nelson D a. Influence of temperature changes on multiple sclerosis: 434 
critical review of mechanisms and research potential. J Neurol Sci. 1995;129(1):1–8. 435 
doi:0022510X9400248M [pii]. 436 
17.  Bishop D. Warm Up I: Potential mechanisms and the effects of passive warm up on 437 
exercise performance. Sport Med. 2003;33(6):439–454. Available at: 438 
http://link.springer.com/article/10.2165/00007256-200333060-00005. 439 
18.  Ashworth B. Preliminary Trial of Carisoprodol in Multiple Sclerosis. Practitioner. 440 
1964;192:540–542. 441 
19.  Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: 442 
report and suggested guidelines from the International Workshop on the Safety of 443 
Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr 444 
Clin Neurophysiol. 1998;108(1):1–16. Available at: 445 
http://www.ncbi.nlm.nih.gov/pubmed/9474057. 446 
20.  Hodkinson HM. Evaluation of a mental test score for assessment of mental 447 
impairment in the elderly. 1972. Age Ageing. 1972;41 Suppl 3:iii35–40. 448 
doi:10.1093/ageing/afs148. 449 
21.  Wade DT, Collin C. The Barthel ADL Index: A standard measure of physical disability? 450 
Int Disabil Stud. 1988;10(2):64–67. 451 
22.  KHOSLA T, LOWE C R. Indices of obesity derived from body weight and height. Br J 452 
Prev Soc Med. 1967;22:122–128. doi:10.1136/jech.21.3.122. 453 
23.  Bromberg MB. An electrodiagnostic approach to the evaluation of peripheral 454 
neuropathies. Phys Med Rehabil Clin N Am. 2013;24(1):153–68. 455 
doi:10.1016/j.pmr.2012.08.020. 456 
24.  Marsden J, Ramdharry G, Stevenson V, Thompson A. Muscle paresis and passive 457 
stiffness: key determinants in limiting function in Hereditary and Sporadic Spastic 458 
Paraparesis. Gait Posture. 2012;35(2):266–71. doi:10.1016/j.gaitpost.2011.09.018. 459 
25.  Buschbacher R. Tibial nerve motor conduction to the abductor hallucis. Am Jounal 460 
Phys Med Rehabil. 1999;78(6):S15–20. 461 
26.  Rothwell JC, Hallett M, Beradelli A, Eisen A, Rossini P, Paulus W. Magnetic 462 
stimulation: motor evoked potentials. The International Federation of Clinical 463 
Neurophysiology. Electroencephalogr Clin Neurophysiol. 1999;52:97–103. 464 
27.  Matsumoto H, Hanajima R, Terao Y, Ugawa Y. Clinical Neurophysiology Magnetic-465 
motor-root stimulation : Review. Clin Neurophysiol. 2013;124(6):1055–1067. 466 
doi:10.1016/j.clinph.2012.12.049. 467 
28.  Ruano L, Silva MC. The Global Epidemiology of Hereditary Ataxia and Spastic 468 
Paraplegia : A Systematic Review of Prevalence Studies. Neuroepidemiology. 469 
2014;42:174–183. doi:10.1159/000358801. 470 
29.  McMonagle PM, Webb S, Hutchinson M. The prevalence of “pure” autosomal 471 
dominant hereditary spastic paraparesis in the island of Ireland. J Neurol Neurosurg 472 
Psychiatry. 2002;(July 2000):43–47. 473 
30.  Brugman F, Wokke JHJ, Scheffer H, Versteeg MHA, Sistermans EA, Berg LH Van 474 
Den. Spastin Mutations in Sporadic Adult-Onset Upper Motor Neuron Syndromes. 475 
Ann Neurol. 2005:865–869. doi:10.1002/ana.20652. 476 
31.  Braschinsky M, Parts K, Maamägi H, Gross-Paju K, Haldre S. Functional assessment 477 
of lower extremities in hereditary spastic paraplegia. Arch Phys Med Rehabil. 478 
2009;90(11):1887–90. doi:10.1016/j.apmr.2009.06.016. 479 
32.  Duning T, Warnecke T, Schirmacher A, et al. Specific Pattern of Early White-Matter 480 
19 
 
Changes in Pure Hereditary Spastic Paraplegia. Mov Disord. 2010;25(12):1986–1992. 481 
doi:10.1002/mds.23163. 482 
33.  Deluca GC, Ebers GC, Esiri MM. The extent of axonal loss in the long tracts in 483 
hereditary spastic paraplegia. Neuropathol Appl Neurobiol. 2004;30(6):576–84. 484 
doi:10.1111/j.1365-2990.2004.00587.x. 485 
34.  Hedera P, Eldevik O, Malik P, Rainier S, Fink J. Spinal cord magnetic resonance 486 
imaging in autosomal dominant hereditary spastic paraplegia. Diagnostic Neuroradiol. 487 
2005;47:730–734. 488 
35.  Klebe S, Stolze H, Kopper F, et al. Gait Analysis of Spontaneous and Hereditary 489 
Spastic Paraplegia. J Neurol. 2004;251:571–578. 490 
36.  Heinrichs K. Superficial Thermal Modalities. Canine Rehabil Phys Ther. 2004:277–491 
288. doi:10.1016/B978-0-7216-9555-6.50020-6. 492 
37.  Erichsen AK, Koht J, Stray-Pedersen A, Abdelnoor M, Tallaksen CME. Prevalence of 493 
hereditary ataxia and spastic paraplegia in southeast Norway: A population-based 494 
study. Brain. 2009;132(6):1577–1588. doi:10.1093/brain/awp056. 495 
38.  Tomoum HY, Badawy NB, Hassan NE, Alian KM. Anthropometry and body 496 
composition analysis in children with cerebral palsy. Clin Nutr. 2010;29(4):477–81. 497 
doi:10.1016/j.clnu.2009.10.009. 498 
39.  Racinais S, Oksa J. Temperature and neuromuscular function. Scand J Med Sci 499 
Sports. 2010;20 Suppl 3:1–18. doi:10.1111/j.1600-0838.2010.01204.x. 500 
40.  Lakie M, Walsh EG, Wright GW. Control and postural thixotropy of the forearm 501 
muscles: changes caused by cold. J Neurol Neurosurg Psychiatry. 1986;49(D):69–76. 502 
41.  Eldreda EB, Lindsleya D, Buchwald J. The effect of cooling on mammalian muscle 503 
spindles. Exp Neurol. 1960:144–157. Available at: 504 
http://www.sciencedirect.com/science/article/pii/0014488660900042. 505 
42.  Price R, Lehmann J, Boswell-Bessette A, Burleigh S, DeLateur B. Influence of 506 
cryotherapy on spasticity at the human ankle. Arch Phys Med Rehabil. 507 
1993;74(3):300–304. 508 
43.  Pagliaro P, Zamparo P. Quantitative evaluation of the stretch reflex before and after 509 
hydro kinesy therapy in patients affected by spastic paresis. J Electromyogr Kinesiol. 510 
1999;9(2):141–8. Available at: http://www.ncbi.nlm.nih.gov/pubmed/10098714. 511 
44.  Kitchen S. Thermal effects. In: Watson T, ed. Electrotherapy: Evidence Based 512 
Practice. 12th ed. London: Churchill Livingstone; 2008:99–114. 513 
45.  Bhimani R, Anderson L. Clinical understanding of spasticity: implications for practice. 514 
Rehabil Res Pract. 2014;2014:279175. doi:10.1155/2014/279175. 515 
46.  Lehmann, JF, de Latour B. Ultrasound, shortwave, microwave, laser, superficial heat 516 
and cold in the treatment of pain. In: Melzack R, Wall P, eds. Textbook of Pain. 4th ed. 517 
Churchill Livingstone; 1999:1383–1397. 518 
47.  Hardy M, Woodall W. Therapeutic effects of heat, cold, and stretch on connective 519 
tissue. J Hand Ther. 1998;11(2):148–156. doi:10.1016/S0894-1130(98)80013-6. 520 
48.  Oosterveld FG, Rasker JJ, Jacobs JW, Overmars HJ. The effect of local heat and 521 
cold therapy on the intraarticular and skin surface temperature of the knee. Arthritis 522 
Rheum. 1992;35(2):146–151. 523 
49.  Behse F, Buchthal F. Normal sensory conduction in the nerves of the leg in man. J 524 
Neurol Neurosurg Psychiatry. 1971;34(4):404–414. doi:10.1136/jnnp.34.4.404. 525 
50.  Flouris AD, Webb P, Kenny GP. Non-invasive assessment of muscle temperature 526 
during rest, exercise, and post-exercise recovery in different environments. J Appl 527 
Physiol. 2015;(3):jap.00932.2014. doi:10.1152/japplphysiol.00932.2014. 528 
20 
 
51.  Jutte LS, Merrick M a, Ingersoll CD, Edwards JE. The relationship between 529 
intramuscular temperature, skin temperature, and adipose thickness during 530 
cryotherapy and rewarming. Arch Phys Med Rehabil. 2001;82(6):845–50. 531 
doi:10.1053/apmr.2001.23195. 532 
 533 
 534 
 535 
 536 
537 
21 
 
 538 
List of Tables and Figures 539 
Tables 540 
Table 1: Group characteristics. 541 
Table 2: Clinical characteristics of pwSP. 542 
Table 3: Changes in neuromuscular impairments with cooling and warming. 543 
 544 
Figures 545 
Figure 1 Participant set up  546 
Figure 2 Changes in walking speed for pwSP and controls following cooling and warming of 547 
the lower leg (mean ± standard error of the mean SEM is indicated) 548 
Figure 3 Changes in foot tap time for pwSP and controls following cooling and warming of 549 
the lower leg(mean ± SEM is indicated) 550 
Figure 4 Changes in Tibial nerve conduction velocity for pwSP and controls with warming 551 
and cooling (mean ± SEM is indicated) 552 
 553 
 554 
 555 
 556 
 557 
 558 
 559 
 560 
 561 
 562 
22 
 
 563 
23 
 
 
 
 
 
 
 
 
 
 
 
